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Abstract There is no eVective way of replacing all the
functions of the larynx in those requiring laryngectomy.
Regenerative medicine oVers promise, but cannot pres-
ently deliver implants with functioning neuromuscular
units. A single well-documented laryngeal transplant in
man was a qualiWed success, but more information is
required before clinical trials may be proposed. We stud-
ied the early response of the larynx to laryngeal trans-
plantation between 17 pairs of NIH minipigs full
matched at the MHC2 locus. Following iterative techni-
cal improvements, pigs had good swallowing and a pat-
ent airway at 1 week. No signiWcant changes in mucosal
blood Xux were observed compared with pre-operative
measurements. Changes in muscle morphology and Wbre
phenotype were observed in transplant muscles retrieved
after 7 days: the levels of fast and slow myosin heavy
chain (MyHC) protein were reduced and embryonic
MyHC was up regulated consistent with denervation
induced atrophy. At 1 week laryngeal transplantation can
result in good swallowing, and is not associated with
clinical evidence of ischemia-reperfusion injury in
MHC-matched pigs.
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In 2008, there were 12,250 new cases of laryngeal cancer in
USA [1], and a signiWcant proportion of these will ulti-
mately require laryngectomy for treatment of primary or
recurrent disease. In addition, there is a smaller, but
severely impaired group of patients with non-functioning
larynges due to benign disease and trauma [2]. Recent che-
moradiation protocols have coincided with modest survival
gains for advanced laryngeal cancer, although sometimes at
the expense of function; laryngectomy remains a mainstay
of treatment. Despite our recent success in clinical airway
tissue engineering [3], there is no practical way of substitut-
ing the complex functions of the larynx using free tissue
transfer, prosthetics or present regenerative medicine tech-
niques. Hence, laryngeal transplantation remains an attrac-
tive solution to the considerable quality-of-life impairment
faced by laryngectomees [4, 5].
The viability of laryngeal transplantation was con-
Wrmed by the single well-documented human laryngeal
transplant recipient [6, 7] who continues to thrive a
decade after transplantation with excellent speech and
normal swallowing [7]. There is also a report of successes
with tracheal transplantation in Colombian patients [8].
These cases demonstrate what may be possible for such
patients, but the lack of detailed information on any other
than the 1998 patient indicates that more pre-clinical work
is needed before laryngeal transplant is a realistic option
for most patients.
In two studies of patients’ views, the main concern was
the level of immunosuppression required by transplant
recipients, especially important as the target population
includes those with cancer [9, 10]. However, most people
would accept a moderate level of risk in return for substan-
tial gains in quality of life [10]. Before examining the
immunological response to grafting, it is essential to mea-
sure the response of grafts to ischemia and reperfusion, as
well as to determine the functional results of laryngeal
transplantation [11]. If we want to separate these responses
from those involved in tissue rejection this needs to be done
using MHC-matched donors and recipients.
Previous work with dogs and rats permitted major pro-
gress, but also had limitations [12–15]. There is a limited
range of immunological probes available for studying
mucosal responses in dogs. Rats require buried, heterotopic
grafts which make repeated observations and functional
assessments impossible [14]. Pigs have genetically well-
deWned strains with a choice of SLA antigen expression
ideal for transplant studies [16], and also have well-
described neuromuscular [17, 18] and mucosal immune
anatomy [19].We developed an orthotopic laryngeal trans-
plantation in NIH minipigs [20] which mirrored the clinical
setting [6] and have previously reported results from the
Wrst 8 h after revascularisation of donor larynges in recipi-
ent pigs [20]. The present paper is a logical extension of our
previous work [18, 20] and is based on the consensus Wnd-
ings of the World’s Wrst symposium on this subject [11].
We aimed to measure the response to transplantation at
1 week. One week is a key milestone as it is the point of
functional rehabilitation for human laryngectomees: the point
at which suYcient healing of the pharyngeal anastomosis
has occurred to permit swallowing and speech rehabilitation
commences. A study of pharygeosophageal reconstruction
after total larygopharyngectomy[21] found that, on aver-
age, patients needed 1.1 days ventilator support and left
hospital after 4.7 days. In the 1998 transplant [6] the patient
had some speech after 1 week.
This study also permitted the training of a group of clini-
cians in techniques, including post-operative care and mon-
itoring which will be relevant to planned clinical trials.
Here, we present functional, vascular and myologic obser-
vations at 48 h and 1 week after transplantation at which time
points we expected to see immune responses to ischaemia–
reperfusion injury and to the onset of rejection, respectively
[22]. The immunological response of the laryngeal mucosa
to transplantation is reported separately.
Materials and methods
Animals
About 34 cc NIH minipigs (median 17 kg, range 26–48;
IAH, Berkshire, UK) were kept under conditions deter-
mined by local and national ethical guidelines. Transplants
were female-into-female/female-into-male to avoid a host
immune response to Y-chromosome-related antigens. Two
weeks’ acclimatisation before intervention was included to
overcome the observed stress responses in pigs that occur
following transportation.
Three days before transplantation a percutaneous endo-
scopic gastrostomy (PEG, Direct Medical Supplies Ltd,
Alton, UK) and femoral dual lumen central line (Vygon,
Gloucester, UK) were inserted under general anaesthesia.
Initially, open gastrostomies at the time of surgery were
planned to permit feeding whilst protecting a healing pha-
ryngeal anastomosis. However, we found in preliminary
studies that the tube could become blocked by consumed
substances in the animal stomach and that the abdominal
surgery appeared to cause the animals distress. Placement
of a PEG 3 days prior to surgery reduced the surgical
trauma and permitted pigs to become accustomed to the
presence and use of a tube in advance of post-operative care.
Likewise, we found that intravenous catheters and
arterial lines placed in the ear or leg were poorly tolerated
for more than short periods of time and were diYcult and123
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tion, a dual-lumen central line was placed and provided
reliable access for drugs and blood sampling for the follow-
ing week.
Postoperative care
To reduce morbidity and mortality, and to improve welfare,
we developed peri-operative care protocols, including high
dependency care [23]. Novel airway management methods,
including a T-tube tracheostomy device (patent pending)
and pain scoring systems were developed and are reported
separately [23]. Dexamethasone (0.06 mg/kg) was adminis-
tered intravenously during anaesthesia. Antibiotics and
non-steroidal anti-inXammatory drugs were given post-
operatively. Opiate analgesia was used. Details of drugs
used are provided in Table 1.
Post-operative feeding used milk (Parnutts Foods Ltd.,
Lincolnshire, UK.). Basic metabolic requirements were cal-
culated as 2.621 £ weight (kg)0.63MJ/day [24] and four
times this amount fed to compensate for the increased met-
abolic rate associated with recovery.
Transplant experiments
Seventeen fully-MHC2-matched, non-immmunosuppressed
transplants were performed using published techniques
[20, 25]. In brief, donor larynges were isolated via mid-
line incisions and perfused with ice-cold University of
Wisconsin solution (Dupont, Newcastle, UK) until eZux
ran clear. The time of retrieval was recorded for each
operation. At induction and after perfusion, mucosal biop-
sies were taken. Removed organs were placed in bags of
University of Wisconsin solution on ice. During this
period of cold ischemia, which mimics the time that may
be involved in transporting donated organs between hos-
pitals, the operating theatre was prepared for the recipient.
Following general anaesthesia and endotracheal intubation,
larynges were removed from recipient pigs using small-
Weld laryngectomy. Ventilation was swapped to a T-tube
tracheotomy to facilitate anaesthesia, post-operative care
and to stent the anastomosis. Implantation used side-side
anastomoses of superior vena cava into recipient right
jugular venous conXuence and right innominate artery
into recipient right common carotid. No attempt was made
to repair nerves since the primary aim was to study/per-
fect the transplant surgery and no functional recovery
would occur by 1 week in any case. We have described
nerve repair elsewhere [18, 26]. Mucosal biopsies were
taken on reperfusion, which marked the end of cold
ischaemia.
Recipients were anaesthetised at 48 h and grafts
inspected via a 00 Hopkins rod telescopes (Karl Storz,
Berkshire, UK). Biopsies and laser Doppler readings were
taken. Recipients underwent a second endoscopy at 7 days,
following which they were killed (barbiturate). Grafts were
photographed and mucosa and muscle sampled.
Mucosal perfusion
In order to assess graft perfusion at the capillary level,
important since major vessel patency may not correlate
with peripheral perfusion in a denervated organ, mucosal
blood Xux was measured midway along the right false
vocal cord using laser Doppler (Moor Instruments, Devon,
UK) at 0 (donor prior to organ recovery), 2 and 7 days [27].
After establishing a steady reading, 30 s recordings were
made.
Functional results
Our T-tube device permits airXow through both tracheot-
omy and larynx. At 1 week, following occlusion of the tra-
cheotomy limb, the ability of the pigs to produce a grunt
and Xow of air through the nose was assessed. VideoXuo-
roscopy at 1 week assessed swallowing.
Table 1 Drugs, and their doses, used peri-operatively and during the transplant operations
Drug Type Dose Duration Source
Cefuroxime Antibiotic 10 mg/kg, IV 8 hourly 7 days GSK, Uxbridge, UK
Metronidazole Antibiotic 10 mg/kg, oral (via PEG) 12 hourly 7 days Hawgreen, Hitchin, UK
Dexamaethasone Steroid 0.06 mg/kg, IV During 
anaesthesia
Intervet UK Ltd, Milton Keynes, 
Bucks UK
Morphine Analgesic 0.2 mg/kg every 4 h initially, 
then titrated using the pain scale
7 days Martindale Pharmaceuticals Ltd, 
Romford, Essex
Ketoprofen (10%) Non-steroidal 
anti-inXammatory
3 mg/kg 7 days Merial Animal Health, 
Harlow Essex UK
Or meloxicam (20 mg/ml) 0.4 mg/kg 7 days Boehringer Ingelheim Ltd, 
Bracknell, Berkshire, UK123
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OCT embedded frozen biopsies of laryngeal muscles were
prepared as previously described [18]. BrieXy, frozen
15 m transverse sections of posterior cricoarytenoid
(PCA) muscle and thyroarytenoid (TA) muscles from con-
trol and transplant animals were incubated with primary
monoclonal myosin heavy chain (MyHC) antibodies
described for western blot analysis below, together with
rabbit anti-laminin antibody (Sigma) to highlight individual
muscle Wbres. Primary antibody was detected using second-
ary antibodies coupled to CY3 or FITC, respectively, and
the sections were then viewed using a Xuorescence micro-
scope (BX60; Olympus, Tokyo, Japan).
Myology: western blotting
Sections of muscle were homogenised in lysis buVer con-
taining 100 mM PIPES, 5 mM MgCl, 20% (v/v) glycerol,
0.5% (v/v) Triton X-100, 5 mM EGTA and protease inhibi-
tors (Sigma, UK). Ten g protein per sample was denatured
at 95°C for 5 min and resolved at 120 V on 10% SDS–
PAGE gels. Following transfer to nitrocellulose, mem-
branes were blocked for 1 h in 5% (w/v) non-fat dry milk in
TBS-Tween, and then incubated overnight at 4°C with
either monoclonal fast WB-MHCf (Leica Biosystems,
Newcastle, UK; 1:2,000) or slow WB-MHCs (Leica Bio-
systems; 1:1,000) or embryonic F1.652 MyHC (Alexis
Corporation, Nottingham, UK; 1:50) antibodies. Following
six 5-min TBS-Tween washes, membranes were incu-
bated for 1 h with HRP-conjugated secondary antibodies
(goat anti-mouse 1:1,000; Cell Signalling Technology,
USA). Membranes were washed and treated with chemi-
luminescent substrate (Amersham, UK) for 1 min. The blots
were then exposed (1–10 min) to light-sensitive Wlm,
scanned and analysed (Scion Image, Scion Corporation,
Maryland, USA).
Statistical methods
Western blotting densitometry was analysed using
Kruskal–Wallis 1-way ANOVA.
Laser-Doppler results were analysed using analysis of
variance (SPSS 12).
Results
Transplant operations
Median time for recovery and implantation were 150 min
(range 108–210; n = 17) and 240 min (165–480), respec-
tively; median cold ischemia time was 340 min (300–540).
There was no diVerence in recovery, cold ischemia or graft
implantation time between successful and unsuccessful
operations (Fig. 1). Iterative improvements in technique
over the Wrst few cases included changing to a dedicated
T-tube tracheotomy device with inner tube, and displacing
the tracheotomy away from the site of anastomosis to reduce
venous compression.
Graft survival, animal mortality and morbidity
Nine grafts were viable, and one more was borderline via-
ble, to the point of censoring. Thus, eight animals were
killed prematurely due to graft failure. In addition, 2 more
pigs were killed due to airway obstruction, despite having
viable grafts. This problem was overcome by developing
the dedicated tube above. Thus, 7/17 animals survived with
viable grafts at 7 days (Table 2).
In the eight experiments where graft failure occurred,
this was apparent by 48 h. Venous obstruction caused four
grafts to fail, a problem later avoided by altering the site of
the tracheotomy; one failed to perfuse on table due to inad-
equate heparinization; two failed to perfuse for unknown
reasons (Table 3). The healthy grafts were deep pink
though edematous at 48 h (Fig. 2a, b); the edema subsided
by 7 days, leaving a paler graft with normal morphology
(Fig. 2c, d). At euthanasia, edema remained in the muscular
compartment in two pigs (Fig. 2e, f).
Fig. 1 Mean time for recovery, implantation and cold ischaemia for
successful and unsuccessful laryngeal transplants. Figure shows mean
with 95% conWdence limits. Filled square successful; opened square
unsuccessful
0
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Table 2 Graft survival, animal mortality and morbidity
Total number of experiments 17
Viable grafts 9 or 10
Recipient alive at 48 h 13
Recipient alive at 7 days 7123
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normal social behaviour with care staV and experienced
negligible weight loss (0.2 kg, range 1- gain 0.5). Minor
complications encountered were wound infection (one) and
wound dehiscence (two). These were easily managed with
local measures.
Mucosal perfusion
Laser Doppler Xux at the initial measurement was 171 arb-
itary units (AU) (range 69–418), there was a small increase
at 48 h to 199 AU (range 48–386) and a small decrease at
7 days to 156 AU (56–247). There was no statistical diVerence
Table 3 Causes of premature death
Cause Number Solution
Viable graft Blocked tracheostomy tube 1 Developed special T-tube, and protocol for airway cleaning
Lost tracheostomy tube 1
Other airway problems 1
Non-viable graft Venous occlusion 4 Enlist help of vascular surgeon, displace the tracheotomy 
away from the site of anastomosis to reduce venous compression
Heparinisation 1 Ensure dose correctly weight adjusted
Prolapsing fat/debris airway 
problems/?dead graft
2
Total 10
Fig. 2 Endoscopic appearance 
of (a), (b) laryngeal transplants 
at 48 h and (c), (d) at 7 days. 
At 48 h, the larynx is highly 
oedematous, whilst a patent 
lumen and visible vocal cords 
reappear by 1 week. Revascular-
ised laryngeal graft 1 week after 
transplantation: (white arrow 
vascular pedicle; black arrow 
vocal cords) on removal (e) and 
sagittally split posteriorly 
(arrow healed tracheal 
anastomosis) (f)123
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cessful experiments (Fig. 3). Laser Doppler measurements
were a useful means of conWrming graft failure, with all
ischemic larynges exhibiting readings of 50 arbitrary units
or less. These values were not included in the analysis.
Functional results
In all seven pigs surviving with healthy grafts to 1 week,
occlusion of the vertical limb of the T-tube resulted in
passage of some air through the larynx. Audible grunts
(‘phonation’) were produced by Wve recipient pigs. In no
case, however, was airXow suYcient to support nasal
breathing at 1 week. Four animals co-operated with video-
Xuoroscopy: three swallowed freely without laryngeal
penetration, aspiration or Wstula (Fig. 4). One pig experi-
enced minor aspiration which cleared on coughing.
Myology
Control muscle sections of posterior cricoarytenoid (PCA;
Fig. 5a) and thyroarytenoid (TA; Fig. 5b) showed large-
diameter Wbres mainly positive for fast-type myosin heavy
chain (MyHC). There was no expression of embryonic
MyHC. However, samples retrieved at 7 days showed
large reductions in Wbre size, mosaic architecture and
immuno-positivity for fast and slow type MyHC (Fig. 5a, b).
Embryonic MyHC was expressed in some muscle Wbres.
Western blotting showed a signiWcant reduction in levels of
Fig. 3 a Laser Doppler Xux 
recordings from a normal larynx 
(top), a successful graft (middle, 
mean Xow 200 arbitrary units) 
and one which subsequently 
failed (bottom, mean < 50). 
b Blue dye injection into pedicle 
shows distribution of blood sup-
ply to all parts of the larynx. The 
supraglottis seemed relatively 
less well perfused, which may 
contribute to the observed lack 
of leukocyte changes in this sub-
site. c Laser Doppler Xuxmetry 
(mean § 95% conWdence limits, 
arbitrary units) of pig laryngeal 
graft mucosal blood Xux at 0 
(donor), 2 and 7 days post- trans-
plantation. Filled square suc-
cessful; opened square 
unsuccessful
Fig. 4 Barium swallow 1 week post-laryngeal transplantation in a
pig. White arrow indicates t-tube tracheostomy within the transplanted
subglottis. Black arrows show normal swallowing of contrast. There
is no aspiration seen123
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MyHC was expressed only in transplanted muscle (Fig. 6).
Discussion
This is the Wrst comprehensive description of the perfor-
mance, management and early outcomes of laryngeal trans-
plantation in a large animal and provides valuable preclinical
data and experience for human trials. Following incremental
technical modiWcations (dedicated T-tube, improved vascu-
lar technique, used of PEG tube and central line) good graft
and pig survival were achieved in this valuable but
labour-intensive model. Mucosal perfusion was sustained
and normal by 1 week in surviving animals. Mucosal oedema
was transient, leading to some airway patency and normal
swallowing at 1 week. Laryngeal muscle morphology and
phenotype altered signiWcantly, consistent with denervation-
induced atrophy. These data provide important baseline
observations for further interventional studies, including
unmatched grafts, long-term survival studies and studies of
reinnervation.
Graft survival and function
Operating times compared favourably with those for other
complex grafts [28, 29]. High morbidity (>50%) is com-
mon in experimental work involving major surgery in pigs.
Fig. 5 Morphology of laryngeal 
muscle Wbres. a Posterior crico-
arytenoid (PCA) muscle. Trans-
verse sections of control PCA 
(top row) and transplant PCA 
(bottom row) muscles stained 
with laminin antibody (green) 
and either fast type, slow type or 
embryonic MyHC protein anti-
body (red). b Thyroarytenoid 
(TA) muscle. Transverse 
sections of control TA (top row) 
and transplant TA (bottom row) 
muscles stained with laminin 
antibody (green) and either fast 
type, slow type or embryonic 
MyHC protein antibody (red)123
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care and operating technique during the series culminated
in 100% peri-operative survival of the Wnal 12 recipients.
We would hope that any future animal or human trial
would have better survival rates. The improvements in sur-
gical technique, such as placement of the graft, would be
applied. Human patients would understand the surgical pro-
cedure and be more likely to comply with requests; for
example, to keep still. In animal trials ethical consider-
ations and licensing rules prevent any further intervention,
whereas in a human if it were apparent that the graft had
failed the graft could be removed.
The combination of videoXuoroscopy, endoscopy, laser
Doppler and measurement of airXow through the T-tube
gave us conWdence that the viable grafts were functional. In
general the graft was not oedematous after 1 week; there-
fore, we think it unlikely that swallowing without aspira-
tion was due to oedema at the superior part of the larynx.
The mucosa of one graft remained oedematous at 1 week.
The one reported human laryngeal graft exhibited initial
oedema which subsided suYciently to permit speech by
1 week [6], as observed in the surviving pig larynges here.
This oedema may represent part of the normal range of
responses, or a response to minor antigen mismatches.
However, our detailed immunological studies (presented in
a separate paper) found no evidence to support the latter.
Mucosal perfusion
We have previously validated the use of laser Doppler Xux-
metry as a measure of laryngeal mucosal blood Xux in man
and pig [27]. Although laser Doppler measurements failed
to predict success and failure in the present study, we found
them useful in making decisions about the viability of
grafts in the early post-operative period and may have clin-
ical utility in this role; further studies would be required.
Myology
In two of Wve grafts for which detailed studies were per-
formed, transplanted muscle was macroscopically identical
to control muscle taken from the recipient’s larynx prior to
implantation. In other samples, breakdown of muscle struc-
ture, reductions in muscle Wbre size and changes in pheno-
type were apparent, despite no signiWcant changes in
appearance or immunohistology of the mucosal compart-
ment in the same larynges. This is most likely to be a con-
sequence of denervation-induced atrophy. In a previous
study on primate laryngeal muscles it was shown that
denervation produced shrinkage of fast-type Wbres within
2 weeks (particularly in the thyroarytenoid) and after
8 weeks all laryngeal muscles showed signiWcant Wbrosis
[30]. Similarly, in a rat model of recurrent laryngeal nerve
Fig. 6 Changes in myosin 
heavy chain protein expression 
in transplanted muscle. 
a Western blots of lysates were 
prepared from the PCA and TA 
muscles from control animals 
(con) and transplanted (trans) 
muscle 7 days following sur-
gery. Samples were electropho-
resed and transferred to 
nitrocellulose membranes as 
described in “Materials and 
methods”. Membranes were 
probed with antibodies directed 
against fast, slow, or embryonic 
type MyHC protein. b Graphs 
show densitometry data as 
mean § SEM values (n = 5 ani-
mals) *P < 0.05; **P < 0.01; 
***P < 0.001 signiWcantly 
diVerent when transplant muscle 
is compared with control muscle123
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cle Wbre size and almost complete loss of synaptophysin-
positive nerve terminals [31] 2 weeks after denervation.
Even as early as 7 days, denervation induces a signiWcant
reduction in muscle weight (which recovers upon reinner-
vation) and decreased Wbre size in rat laryngeal muscles,
with a large reduction in type IIB myosin heavy chain
protein [32]. This is consistent with our results showing a
signiWcant fall in fast-type MyHC protein levels; we have
previously shown that type IIB MyHC predominates in pig
laryngeal muscle [18]. One study [33] suggests slow type I
MyHC is relatively unaVected by denervation, but another
indicates that over a longer time-course there is a progres-
sive reduction in expression [34]. We also observed a
“reactivation” of embryonic myosin heavy chain protein in
transplanted muscles. This suggests to us that the atrophic
changes occurring as a result of denervation can trigger a
regenerative response mimicking the developmental pro-
cesses of muscle formation [35]. Indeed, recent studies
indicate that compared with limb muscles, laryngeal muscle
has an enhanced ability to respond to denervation as the
result of a robust addition of myonuclei and myoWbre
remodelling due to intrinsic activation of muscle satellite
cells [36, 37]. Thus, further studies are warranted to deter-
mine how functional reinnervation might be achieved fol-
lowing laryngeal transplantation. Lack of sensory innervation
at 1 week was probably the cause of the minor aspiration
noted in one animal, though its absence in the other four
undergoing videoXuoroscopy was encouraging.
Conclusion
This is the Wrst detailed study of the acute vascular and myo-
logic outcomes of laryngeal transplantation in a preclinical
model. At 1 week, laryngeal transplants between pigs fully
matched at the MHC2 loci are characterised by good func-
tion as measured by swallowing and ‘phonation’. Laryngeal
muscle displays signs of denervation induced atrophy, but
the “reactivation” of embryonic MyHC is encouraging,
suggesting that the muscle can actively mount a regenera-
tive response after transplantation. The knowledge and
skills we have gained from this 1-week study would permit
us to progress, subject to licensing and ethical approval,
with more conWdence to longer term studies, in which the
function of the graft can be robustly tested over several
weeks or months. These studies provide a Wrm scientiWc
basis on which to interpret the response to allografting in
this robust pre-clinical model.
This study also provides some evidence and in vivo
experience and training which would support subsequent
clinical trials.
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